Reassessment of genotype 1 hepatitis C virus subtype misclassification by LiPA 2.0: implications for direct-acting antiviral treatment
about
Using NS5B Sequencing for Hepatitis C Virus Genotyping Reveals Discordances with Commercial Platforms.Hepatitis C virus genotype 4 resistance and subtype demographic characterization of patients treated with ombitasvir plus paritaprevir/ritonavir.Consequences of inaccurate hepatitis C virus genotyping on the costs of prescription of direct antiviral agents in an Italian district.Detection of Natural Resistance-Associated Substitutions by Ion Semiconductor Technology in HCV1b Positive, Direct-Acting Antiviral Agents-Naïve PatientsPrevalence and distribution of hepatitis C virus genotypes in Spain during the 2000-2015 period (the GEHEP 005 study).NS3 genomic sequencing and phylogenetic analysis as alternative to a commercially available assay to reliably determine hepatitis C virus subtypes 1a and 1b.Characterization of Samples Identified as Hepatitis C Virus Genotype 1 without Subtype by Abbott RealTime HCV Genotype II Assay Using the New Abbott HCV Genotype Plus RUO Test.A novel standardized deep sequencing-based assay for hepatitis C virus genotype determination.
P2860
Q35994877-D6F08A75-9E92-456C-9444-14CD1985EFE6Q36158361-E263C735-3D20-477C-854E-739A1DAABE85Q37265764-7E58E805-321C-426E-90FB-7828402FA6C7Q37286311-2E571B9F-91C6-4C1F-A820-B0E942C2F8BAQ38935930-931FBF92-A3F6-4A70-B657-120346589993Q40104062-F54ED8A2-DAC6-4BAF-885B-B2963CF082A4Q41114226-47F175CE-444C-43D9-8CB3-39B804E267F4Q52665728-0E2D29E4-B299-4C51-B724-0D62B2750CA0
P2860
Reassessment of genotype 1 hepatitis C virus subtype misclassification by LiPA 2.0: implications for direct-acting antiviral treatment
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Reassessment of genotype 1 hep ...... ect-acting antiviral treatment
@ast
Reassessment of genotype 1 hep ...... ect-acting antiviral treatment
@en
type
label
Reassessment of genotype 1 hep ...... ect-acting antiviral treatment
@ast
Reassessment of genotype 1 hep ...... ect-acting antiviral treatment
@en
prefLabel
Reassessment of genotype 1 hep ...... ect-acting antiviral treatment
@ast
Reassessment of genotype 1 hep ...... ect-acting antiviral treatment
@en
P2093
P2860
P50
P356
P1476
Reassessment of genotype 1 hep ...... ect-acting antiviral treatment
@en
P2093
Federico A Di Lello
Javier R Guelfo
Jose A Mira
María Mancebo
Rocío Nuñez-Torres
P2860
P304
P356
10.1128/JCM.02209-14
P407
P577
2014-08-20T00:00:00Z